Comparison of the Efficacy and Safety of 2 Oral Doses of Rimonabant, 5 mg/Day or 20 mg/Day, Versus Placebo, as an Aid to Smoking Cessation (STRATUS US)

PHASE3CompletedINTERVENTIONAL

Enrollment

787

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions

Smoking Cessation

Interventions

DRUG

Rimonabant

Trial Locations (1)

Sanofi-Aventis Administrative Office, Malvern